Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
62
PharmaCompass offers a list of Inosine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Inosine manufacturer or Inosine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Inosine manufacturer or Inosine supplier.
PharmaCompass also assists you with knowing the Inosine API Price utilized in the formulation of products. Inosine API Price is not always fixed or binding as the Inosine Price is obtained through a variety of data sources. The Inosine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Atorel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atorel, including repackagers and relabelers. The FDA regulates Atorel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atorel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Atorel supplier is an individual or a company that provides Atorel active pharmaceutical ingredient (API) or Atorel finished formulations upon request. The Atorel suppliers may include Atorel API manufacturers, exporters, distributors and traders.
click here to find a list of Atorel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Atorel DMF (Drug Master File) is a document detailing the whole manufacturing process of Atorel active pharmaceutical ingredient (API) in detail. Different forms of Atorel DMFs exist exist since differing nations have different regulations, such as Atorel USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Atorel DMF submitted to regulatory agencies in the US is known as a USDMF. Atorel USDMF includes data on Atorel's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Atorel USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Atorel suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atorel as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atorel API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atorel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atorel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atorel NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atorel suppliers with NDC on PharmaCompass.
Atorel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Atorel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Atorel GMP manufacturer or Atorel GMP API supplier for your needs.
A Atorel CoA (Certificate of Analysis) is a formal document that attests to Atorel's compliance with Atorel specifications and serves as a tool for batch-level quality control.
Atorel CoA mostly includes findings from lab analyses of a specific batch. For each Atorel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Atorel may be tested according to a variety of international standards, such as European Pharmacopoeia (Atorel EP), Atorel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Atorel USP).
